The Juvenile Diabetes Research Foundation will team up with Animas Corporation, a subsidiary of Johnson and Johnson, to create an “artificial pancreas,” the diabetes charity has announced.

The New York-based JDRF has pledged $8 million to develop the device, which would combine an insulin pump with a continuous glucose monitor (CGM), running algorithms that would automatically control the amount of insulin dripped throughout the day.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!